Multiple antigen stimulating cellular therapy (MASCT)-I for metastatic urothelial carcinoma (mUC): A multicenter, phase I study (MASCT-I-1001)

被引：0
|
作者：
Shi, Yanxia
Chen, Meiting
An, Xin
Xue, Cong
Shu, Ditian
Li, Haifeng
Huang, Riqing
Qin, Zike
Li, Yonghong
Wu, Zhiming
Yao, Kai
Liu, Zhuowei
Zhou, Fangjian
Weng, Desheng
Zhang, Xing
Xu, Ruihua
机构：
[1] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Dept Med Oncol, Canc Ctr, Guangzhou, Peoples R China
[3] State Key Lab Oncol South China, Guangzhou, Peoples R China
[4] Collaborat Innovat Ctr Canc Med, Guangzhou, Peoples R China
[5] Sun Yat Sen Univ, Dept Urol, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China
[6] Sun Yat Sen Univ, Dept Urol, Canc Ctr, Guangzhou, Peoples R China
[7] Sun Yat Sen Univ, Melanoma & Sarcoma Med Oncol Unit, Canc Ctr, Guangzhou, Peoples R China
[8] Sun Yat Sen Univ, State Key Lab Oncol South China, Dept Med Melanoma & Sarcoma, Collaborat Innovat Ctr Canc Med,Canc Ctr, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16572
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase I study of [131 I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol
    Thivat, Emilie
    Rouanet, Jacques
    Auzeloux, Philippe
    Sas, Nicolas
    Jouberton, Elodie
    Levesque, Sophie
    Billoux, Tommy
    Mansard, Sandrine
    Molnar, Ioana
    Chanchou, Marion
    Fois, Giovanna
    Maigne, Lydia
    Chezal, Jean-Michel
    Miot-Noirault, Elisabeth
    D'Incan, Michel
    Durando, Xavier
    Cachin, Florent
    [J]. BMC CANCER, 2022, 22 (01)
  • [42] Gemcitabine in combination with capecitabine in metastatic breast carcinoma: A phase I-II study.
    Giannessi, PG
    Martella, F
    Di Marsico, R
    Coltelli, L
    Safina, V
    Andreuccetti, M
    Falcone, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 95S - 95S
  • [43] Phase I Study of Dalteparin in Combination With Sunitinib in Patients With Metastatic Clear Cell Renal Carcinoma
    Wentink, Madelon Q.
    Verheul, Henk M. W.
    Pal, Sumanta K.
    George, Saby
    Voortman, Johannes
    Danchaivijitr, Pongwut
    Adelaiye, Remi
    Poslinski, Diane
    Groman, Adrienne
    Hutson, Alan
    Pili, Roberto
    [J]. CLINICAL GENITOURINARY CANCER, 2018, 16 (01) : E1 - E9
  • [44] Phase I–II Parallel Study of Docetaxel on a Bimonthly Schedule in Refractory Metastatic Breast Carcinoma
    Vittorio Gebbia
    Nicolò Borsellino
    Antonio Testa
    Maria Lina Tirrito
    Patrizia Ferrera
    Alfredo Colombo
    Gaetano Mauceri
    Antonio Marrazzo
    Ferdinando Porretto
    Maurizio Musso
    [J]. Breast Cancer Research and Treatment, 2003, 77 : 99 - 108
  • [45] Phase I study of nivolumab in combination with ipilimumab (IPI) in metastatic renal cell carcinoma (mRCC)
    Hammers, H.
    Plimack, E. R.
    Infante, J. R.
    Ernstoff, M. S.
    Rini, B.
    Mcdermott, D. F.
    Razak, A.
    Pal, S. K.
    Voss, M. H.
    Sharma, P.
    Kollmannsberger, C.
    Heng, D. Y. C.
    Spratlin, J.
    Shen, Y.
    Kurland, J. F.
    Gagnier, P.
    Amin, A.
    [J]. BJU INTERNATIONAL, 2014, 114 : 8 - 8
  • [46] A phase I study of everolimus plus sorafenib in patients with metastatic renal cell carcinoma (mRCC)
    Cen, P.
    Daleiden, A.
    Doshi, G.
    Amato, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [47] Phase I study of IV vinorelbine and capecitabine as first line treatment in metastatic breast carcinoma
    Favier, Laure
    Mayer, Francoise
    Chauffert, Bruno
    Zanetta, Sylvie
    de Gislain, Catherine
    Fumoleau, Pierre
    Fargeot, Pierre
    Garnier, Jerome
    Biville, Fabienne
    Coudert, Bruno
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 52 - 53
  • [48] A phase I study of pembrolizumab in combination with enadenotucirev (EnAd) (SPICE) in subjects with metastatic or advanced carcinoma
    Harb, Wael A.
    Cerec, Virginie
    McElwaine-Johnn, Hilary
    Champion, Brian
    Alvis, Simon
    Jain, Nitin
    Ellis, Christopher
    Fisher, Kerry
    Beadle, John William
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [49] The Double Antibody Drug Conjugate (DAD) phase I trial: sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinoma
    McGregor, B. A.
    Sonpavde, G. P.
    Kwak, L.
    Regan, M. M.
    Gao, X.
    Hvidsten, H.
    Mantia, C. M.
    Wei, X. X.
    Berchuck, J. E.
    Berg, S. A.
    Ravi, P. K.
    Michaelson, M. D.
    Choueiri, T. K.
    Bellmunt, J.
    [J]. ANNALS OF ONCOLOGY, 2024, 35 (01) : 91 - 97
  • [50] Phase I clinical and plasma and cellular pharmacological study of topotecan without and with granulocyte colony-stimulating factor
    Abbruzzese, JL
    Madden, T
    Sugarman, SM
    Ellis, AL
    Loughlin, S
    Hess, KR
    Newman, RA
    Zwelling, LA
    Raber, MN
    [J]. CLINICAL CANCER RESEARCH, 1996, 2 (09) : 1489 - 1497
12345